0001144204-14-027196.txt : 20140502 0001144204-14-027196.hdr.sgml : 20140502 20140502163043 ACCESSION NUMBER: 0001144204-14-027196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140430 FILED AS OF DATE: 20140502 DATE AS OF CHANGE: 20140502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 155 GIBBS STREET STREET 2: SUITE 412 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 155 GIBBS STREET STREET 2: SUITE 412 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANZER STEVE H CENTRAL INDEX KEY: 0001076653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 14809785 4 1 v377084_4.xml OWNERSHIP DOCUMENT X0306 4 2014-04-30 1 0000894158 Synthetic Biologics, Inc. SYN 0001076653 KANZER STEVE H C/O PHARMAINVESTORS, LLC 9045 LA FONTANA BLVD, SUITE 238 BOCA RATON FL 33434 0 0 1 1 Prior Director Common Stock 2014-04-30 4 S 0 5003025 1.43 D 2195489 I By: Accredited Venture Capital, LLC Represents weighted average price per share for the toal number of shares sold. These shares were sold in multiple transactions at prices ranging from $2.01 to $1.25, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Of these shares beneficially owned, 375,246 shares are owned directly by Mr. Kanzer and 1,820,243 shares are held indirectly in the name of Accredited Venture Capital, LLC. Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC. /s/ Steve H. Kanzer 2014-05-02